StockData
BioXcel Therapeutics, Inc. logo

BioXcel Therapeutics, Inc. (BTAIQ) stock

BTAIQOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026Score 3/30
$0.03−0.00 (-13.49%)

Close on Oct 19, 2026Market cap $757.50KP/E –Yield –

BioXcel Therapeutics market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

BioXcel Therapeutics's market cap was $782.63K on Oct 19, 2026, against $13.57M a year earlier. Over the last 5 years it ranged from $782.63K to $898.45M, with a median of $74.05M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Oct 19, 2026$782.63K-97.6%
2025Dec 31, 2025$31.99M+101.5%
2024Dec 31, 2024$15.88M-81.6%
2023Dec 29, 2023$86.36M-85.7%
2022Dec 30, 2022$601.93M+5.8%
2021Dec 31, 2021$568.83M-49.4%
2020Dec 31, 2020$1.13B+327.0%
2019Dec 31, 2019$263.49M+336.3%
2018Dec 31, 2018$60.39M–

More BioXcel Therapeutics figures

See a number that looks wrong?